Market Highlights

• Archon Biosciences, a biotech company advancing computationally designed Antibody Cages (AbCs), raised $20.0 million in seed funding led by Madrona Ventures and other key investors.
• After two years of construction, Lincoln Property Company has completed its nearly 200,000-square-foot (sf) lab development at 222 Fifth Avenue.
• KKR purchased the vacant 211,000-sf life sciences building at 330 Yale in Seattle for $161.8 million and plans to invest $7.2 million more in upgrades, including 35,000 sf of speculative lab suites.

Read the full report